Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tissuefill is a soft tissue augmentation agent composed of hyaluronic acid derivatives. It is used as a dermal filler for facial aesthetic procedures, including full-face augmentation. The product can be mixed with platelet-rich plasma (PRP) to enhance outcomes, as seen in the Q.O.Fill method. Hyaluronic acid fillers like Tissuefill work by restoring volume and smoothing wrinkles through subcutaneous injection, leveraging the hydrophilic properties of hyaluronic acid to attract water and provide structural support in the skin. Clinical studies have shown that injections with Tissuefill (with or without PRP) result in significant aesthetic improvement and high patient satisfaction rates, with a low incidence of complications[2]. The effects are temporary and may require repeat treatments for maintenance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tissuefill.